BPLPHARMA · Bharat Parenterals Limited · Financials
Market Cap
14.65B INR
Shares
6.89M
Volume · Nov 13
2425
Avg daily vol (3M)
1959
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
3.45B
+1.5%
FY2026
Net Income
-81.88M
FY2026
Operating Cash Flow
383.62M
+240.7%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 |
|---|---|---|---|
| INR | 3.95B | 3.45B | 3.4B |
| INR | 347.8M | 342.51M | 353.2M |
| INR | 113.13M | 125.35M | 129.5M |
| INR | -41.53M | -214.23M | -339.5M |
| INR | 54.21M | 58.82M | 92.2M |
| INR | 12.44M | -81.88M | 0 |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2025–FY2026: 12.68M in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.